EI
BSX icon

Ethic Inc’s Boston Scientific BSX Stock Holding History

Ethic Inc’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.92M Sell
208,937
-18,280
-8% -$993K 0.11% 180
2026
Q1 		$14.3M Sell
227,217
-12,130
-5% -$970K 0.22% 85
2025
Q4 		$22.8M Sell
239,347
-234
-0.1% -$22.9K 0.35% 42
2025
Q3 		$23.4M Sell
239,581
-28,738
-11% -$2.98M 0.38% 32
2025
Q2 		$28.6M Sell
268,319
-529
-0.2% -$53.5K 0.51% 21
2025
Q1 		$27.2M Buy
268,848
+26,919
+11% +$2.71M 0.55% 21
2024
Q4 		$21.6M Buy
241,929
+46,946
+24% +$4.13M 0.44% 30
2024
Q3 		$13.4M Sell
194,983
-21,479
-10% -$1.69M 0.34% 52
2024
Q2 		$16.7M Buy
216,462
+21,479
+11% +$1.57M 0.39% 39
2024
Q1 		$13.4M Buy
194,983
+19,001
+11% +$1.22M 0.34% 52
2023
Q4 		$10.2M Buy
175,982
+10,646
+6% +$568K 0.3% 62
2023
Q3 		$8.73M Buy
165,336
+12,470
+8% +$654K 0.31% 63
2023
Q2 		$8.27M Buy
152,866
+6,241
+4% +$326K 0.31% 64
2023
Q1 		$7.34M Buy
146,625
+17,655
+14% +$832K 0.3% 74
2022
Q4 		$5.97M Buy
128,970
+13,082
+11% +$566K 0.32% 69
2022
Q3 		$4.49M Buy
115,888
+18,959
+20% +$761K 0.3% 76
2022
Q2 		$3.61M Buy
96,929
+18,281
+23% +$744K 0.25% 99
2022
Q1 		$3.48M Buy
78,648
+11,979
+18% +$519K 0.24% 100
2021
Q4 		$2.83M Buy
66,669
+6,895
+12% +$290K 0.22% 114
2021
Q3 		$2.59M Buy
59,774
+7,797
+15% +$345K 0.27% 89
2021
Q2 		$2.22M Buy
51,977
+18,058
+53% +$760K 0.27% 83
2021
Q1 		$1.31M Buy
33,919
+14,693
+76% +$556K 0.23% 105
2020
Q4 		$691K Sell
19,226
-1,979
-9% -$71.3K 0.18% 139
2020
Q3 		$810K Buy
21,205
+14,449
+214% +$557K 0.31% 84
2020
Q2 		$237K Buy
+6,756
New +$243K 0.13% 207
2020
Q1 		– Sell
-5,445
Closed -$246K – 214
2019
Q4 		$246K Buy
+5,445
New +$228K 0.18% 179

Other funds holding BSX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Ethic Inc's BSX Position: Q2 2026 in Review

Ethic Inc reduced its Boston Scientific (BSX) stake by 8% in Q2 2026, selling an estimated $993K and leaving 208,937 shares worth $8.92M. The position accounts for 0.11% of the portfolio, ranked #180.

Ethic Inc first reported a position in BSX in Q4 2019 and has held it in 26 quarters since. The position peaked at $28.6M in Q2 2025. 467 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Ethic Inc held 208,937 shares of Boston Scientific worth $8.92M as of Q2 2026.
  • Ethic Inc sold 18,280 Boston Scientific shares in Q2 2026, an estimated $993K.
  • Boston Scientific made up 0.11% of Ethic Inc's portfolio in Q2 2026, its #180 holding.
  • Ethic Inc first reported a position in Boston Scientific in Q4 2019 and has held it in 26 quarters since.
  • Ethic Inc's Boston Scientific position peaked at $28.6M in Q2 2025.
  • 467 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Ethic Inc's 13F filing for Q2 2026, filed 29 Jul 2026.